[1] |
YAO Qian, CHEN Yun, SHANG Juan, XI Xiaoyun, CHEN Ying, GU Xiao, JU Wenzheng, ZOU Jiandong, LU Su, XU Meijuan.
Investigation of potential pharmacodynamic substances and mechanism of Qingxin-zishen prescription decoction in treatment of menopause syndrome based on HPLC-Q-TOF-MS/MS and network pharmacology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 481-497.
|
[2] |
GUO Lu, ZHONG Zhendong, HAN Yicen, SHI Yi, YANG Yong, BIAN Yuan, LIU Xiaoshu, ZHANG Jing, LANG Qin, ZHONG Tian.
Effects of different administration methods on the pharmacokinetics and tissue distribution of ribavirin in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 25-32.
|
[3] |
HU Yin, YANG Dandan, XU Yichao, SHAO Rong, RUAN Zourong, JIANG Bo, CHEN Jinliang, LOU Honggang.
Application of artificial neural network model in bioequivalence study of candesartan cilexetil tablets
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 63-69.
|
[4] |
CAI Mingmin, SHAO Jing, TANG Lu, SUN Qiuyue, DOU Ting, QIAN Wei, WANG Huiping.
Bioequivalence study of buthlphthalide injection in Chinese healthy volunteers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 70-76.
|
[5] |
XU Guofang, ZHANG Sisen, LIU Ping, MEI Jiazhuan, LIU Weiwei, LIU Ya'ou, QI Qi.
Population pharmacokinetics of capecitabine in Chinese breast cancer patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 552-559.
|
[6] |
LIU Chang, DENG Kunhong, HUANG Jie, YANG Shuang, YANG Xiaoyan, XIANG Yuxia, HUANG Lu, ZHANG Zeyu, LIANG Wenzhong, LAN Jing, YANG Guoping.
Bioequivalence of moxifloxacin hydrochloride tablets in healthy Chinese subjects
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(12): 1393-1399.
|
[7] |
YU Tianyi, JIAO Guangyang, HUANG Doudou, CHEN Yong, XU Deduo, QIU Shi, CHEN Wansheng, ZHANG Feng, WANG Bolong.
Analysis of the effective components and mechanism of Yufang Fangji II for prevention of COVID-19 based on UHPLC-Q-TOF/MS and network pharmacology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1127-1145.
|
[8] |
YANG Qinyan, HUANG Li, SHI Lan, OU Yuanyuan, LI Guoyuan, HUANG Chengyong.
Median effective plasma concentration of propofol inhibiting body movement when combined with butorphanol in patients undergoing hysteroscopic surgery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1033-1037.
|
[9] |
GUO Mingxing, GUO Heng, SHEN Su, SUN Liying, CUI Xiangli.
Retrospective analysis of voriconazole in the monitoring of therapeutic drugs in patients with liver dysfunction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 757-763.
|
[10] |
CHEN Chao, ZHENG Qingshan, LI Lujin, LI Xue, XU Ling.
Comparison of the calculation approaches of AUC in non-compartment model pharmacokinetics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1381-1387.
|
[11] |
CHEN Aiying, CHENG Min, MIAO Yunping, YE Xiaodi, TIAN Xuejun, ZHENG Gaoli.
Pharmacokinetics and tissue distribution characteristics of sunitinib#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(10): 1105-1110.
|
[12] |
XU Yichao, LOU Honggang, RUAN Zourong, CHEN Jinliang, JIANG Bo, SHAO Rong, YANG Dandan.
Bioequivalence of bosentan tablets in healthy Chinese volunteers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(6): 675-680.
|
[13] |
WANG Mengyao,HUANG Jie, LIU Yanan, YANG Shuang, WU Shuting, YANG Xiaoyan, YE Ling, GUO Can, HUANG Zhijun.
Study on bioequivalence of gefitinib tablets in healthy Chinese subjects
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1275-1280.
|
[14] |
LI Li, LI He, LIU Xing'e, WEI Nan.
Determination of apatinib in tumor patients' plasma by liquid chromatography tandem mass spectrometry and its application
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 790-795.
|
[15] |
CHEN Yaoyao,SHI Daohua,LIU Guanghua,NIU Peiguang,LIU Baichen.
Effects of OCT2 and MDR1 gene polymorphisms on vancomycin concentration and clinical efficacy in infants
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 154-158.
|